AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2026 Issue 1; Section X – New Technology

Introduction of New Therapeutic Substances

In table XW0, Introduction of Anatomical Regions, three new substance values were added for the substances listed below with the qualifier value B New Technology Group 11.Substances 0 Alpha1-proteinase Inhibitor 1 Anitocabtagene Autoleucel Immunotherapy 4 Somatic Stem Cells Substance values 0 Alpha 1-proteinase Inhibitor and 1 Anitocabtagene Autoleucel Immunotherapy, were added for the body part values 3 Peripheral Vein and 4 Central Vein. Substance value 4, Stem Cells, Somatic, was added to the body part value 5 Peripheral Artery.Alpha1-proteinase InhibitorAn alpha1-proteinase inhibitor (A1-PI) causes the retention of the alpha-1 antitrypsin (AAT) protein. A1-PI may be combined...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.